Medicrea International SAのEPS 1株当たり利益
Medicrea International SAのEPS 1株当たり利益 は何ですか。
Medicrea International SAのEPS 1株当たり利益 は-0.74です。
EPS 1株当たり利益 の定義は何ですか。
1株当たり利益（EPS) は、当社の1株当たり利益です。それは株式の希釈を考慮に入れ、 過去12ヶ月間にカウントされます。
Earnings per share is the monetary value of earnings per outstanding share of common stock for a company. Preferred stock rights have precedence over common stock. Therefore, dividends on preferred shares are subtracted before calculating the EPS. When preferred shares are cumulative, annual dividends are deducted whether or not they have been declared. Dividends in arrears are not relevant when calculating EPS. The EPS is usually calculated as profit without preferred dividends divided by weighted average of common stock shares over the past twelve months.
LSEのセクタHealth CareにおけるEPS 1株当たり利益 の企業と比べるMedicrea International SA
Medicrea International SAは何をしますか。
Medicrea International SA designs, manufactures, and distributes spinal implants in France and internationally. It offers PASS range, a polyaxial spine system; PASS LP, a thoraco-lumbar fixation system; LigaPASS, a band connector for posterior thoracolumbar fixation; PASS TULIP, a top loading posterior fixation system; PASS DEGEN for thoracic and lumbar degenerative indications; PASS OCT, an occipito-cervico-thoracic fixation system; PASS MIS, a posterior anchoring system; PASS Antérieur that offers a range of specific implants enabling surgery using an anterior approach; IMPIX C, a sterile PEEK Optima cervical interbody device; IMPIX-C+, a sterile PEEK Optima cervical interbody device that is prefilled with bone substitute; and IMPIX-MANTA, a sterile PEEK Optima cervical interbody device that is preassembled on holder/ impactor and delivers with a disposable instrumentation kit. Its implants for cervical spine also include IMPIX-MANTA +, a sterile PEEK Optima cervical interbody device, which is prefilled with synthetic bone substitutes; and GRANVIA-C, a MRI compatible ceramic cervical disc. In addition, it provides implants for the thoracic and lumbar spine, such as IMPIX-L, a sterile PEEK Optima lumbar interbody device for posterior approach; IMPIX-TLIF, a sterile PEEK Optima lumbar interbody device for transforaminal approach with a pre-assembled PEEK control lead; IMPIX-ALIF, a sterile PEEK Optima lumbar interbody device for anterior approach; STABOLT, an anatomically-shaped anterior plate; OSMOSYS, a macroporous bone substitute; IMPIX-DLIF and IMPIX-DLIF SLIM sterile PEEK Optima lumbar interbody devices for direct or oblique lateral approach; and X-JAWS, a titanium lumbar staple to secure a lateral or an anterior cage. Its implants are designed to treat scoliosis, degenerative diseases, malformations, trauma, and tumors; and used in various traditional and surgical procedures. The company was founded in 1990 and is headquartered in Rillieux-la-Pape, France.
Medicrea International SAと類似のeps 1株当たり利益
- Worldline SAのEPS 1株当たり利益 は-0.75です。
- LucidのEPS 1株当たり利益 は-0.75です。
- Boussard & GavaudanのEPS 1株当たり利益 は-0.74です。
- Troc De L'ile SaのEPS 1株当たり利益 は-0.74です。
- Atlantic Sapphire ASAのEPS 1株当たり利益 は-0.74です。
- Asanko GoldのEPS 1株当たり利益 は-0.74です。
- Medicrea International SAのEPS 1株当たり利益 は-0.74です。
- Excellon ResourcesのEPS 1株当たり利益 は-0.74です。
- Royal Boskalis Westminster NVのEPS 1株当たり利益 は-0.74です。
- Integrated Wellness Acquisition CorpのEPS 1株当たり利益 は-0.74です。
- MEDIAN Technologies SAのEPS 1株当たり利益 は-0.74です。
- Ocado PlcのEPS 1株当たり利益 は-0.74です。
- China Eco-FarmingのEPS 1株当たり利益 は-0.74です。